Kelley John P

Avg. Two Year Performance

(46%) Avg. Purchase Return
(21%) Compound
44% Avg. Sale Return
20% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return10%24%11%49%(46%)
Purchase Success Rate1 of 11 of 11 of 11 of 10 of 1
Average Sale Return7%18%35%29%44%
Sale Success Rate3 of 44 of 44 of 43 of 44 of 4
Drugs » Drug Manufacturers - Other

President and COO, Director:

Holdings: 55.62K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 1.28M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--